Application of circulating tumor DNA liquid biopsy in nasopharyngeal carcinoma: A case report and review of literature
The results of ctDNA-based liquid biopsy can serve as an independent biomarker, either independently or in conjunction with EBV DNA status, to guide the treatment and predict the prognosis of NPC.
Authors
- Qiao Qiao (ORCID: https://orcid.org/0000-0002-0229-4407)
- Xinhui Zhou (ORCID: https://orcid.org/0000-0002-0202-7958)
- Donghui Han (ORCID: https://orcid.org/0000-0002-3742-4355)
- Xiaoming Guo (ORCID: https://orcid.org/0000-0002-8919-5750)
- Yao Liu (ORCID: https://orcid.org/0000-0002-6393-4295)
- Yuanjun Jiang (ORCID: https://orcid.org/0000-0002-1201-320X)
Institutions
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- World Journal of Clinical Cases
- Published
- 2025-04-26
- DOI
- https://doi.org/10.12998/wjcc.v13.i21.105066
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00